Holistic Molecular Approaches for Anticancer Therapy
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2012, Vol 1, Issue 1
Abstract
Cancer is a threat concomitant with human history. Although we have stepped into the very advanced twenty first century with considerable progress in cancer treatment, it is still a very difficult disease to treat and is the second most common disease that causes mortality. In recent years, the discovery of new anticancer drugs has evolved from a dramatic shift from cell based screening for anti proliferative effects to a more mechanistically based approach that targets the specific molecular lesions thought to be responsible for the development and maintenance of the malignant phenotype in various forms of cancer. The development of molecularly targeted drugs has improved the efficacy and selectivity of cancer treatment by exploiting the differences between cancer cells and normal cells. Targeted therapies are now a component of treatment for many types of cancer, including breast, colorectal, lung and pancreatic as well as lymphoma, leukemia and multiple myeloma. In order to enhance the specificity and efficacy of current cancer therapies, the aim of this review is to shed light on some of the important molecular targets.
Authors and Affiliations
Dr. Gousia Chashoo*| Pharmacology Division, Indian Institute of Integrative Medicine, canal road, Jammu., Dr. Shashank K Singh| Pharmacology Division, Indian Institute of Integrative Medicine, canal road, Jammu., Dr. Naveed A Qazi| Medicinal chemistry Division, Indian Institute of Integrative medicine, canal road, Jammu., Dr. Ajit K Saxena| Pharmacology Division, Indian Institute of Integrative Medicine, canal road, Jammu.
Validation of Reference Genes for Reliable Gene Expression Study in Human Glioblastoma Multiformeand Neural Stem Cell Lines
Glioblastoma multiforme (GBM) is the most deadly malignant brain tumor in adults. GBM has a histologically heterogeneous group of neoplastic cells which are postulated to be the mediator of anti-cancer therapy resistance...
The Role and Significance of C – Reactive Protein in Neonatal Sepsis: A Clinical Investigation
OBJECTIVE: To evaluate the role of CRP in the management of neonatal sepsis in a NICU setting where resources for diagnosis and monitoring prognosis is minimal. METHODOLOGY: The study was conducted at Dr. B.R. Ambedkar...
Nanoparticle Based Drug Delivery System: Milestone for Cancer Therapy
The challenge of modern drug therapy is the optimization of the pharmacological action of the drugs coupled with the reduction of their toxic effects in vivo. The prime objectives in the design of drug delivery systems...
NASAL CARRIAGE OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AMONG MEDICAL STAFF AT OMDURMAN TEACHING HOSPITAL
Background: methicillin-resistant Staphylococcus aureus( MRSA) is a strain of Staphylococcus aureus which is resistant to methicillin and other antibiotics. Staphylococcus aureus is an organism that colonizes mainly in t...
PREVALENCE OF HERPES SIMPLEX VIRUS IN CSF SPECIMENS OF NEONATES WITH ENCEPHALITIS BY USING REAL TIME PCR
Background: Herpes simplex virus (HSV) causes a spectrum of clinical manifestations in the central nervous system (CNS). Neonatal HSV infection following exposure to the virus at delivery produces severe disseminated in...